Neural Therapeutics, Inc. (NURL.CX)

0.02 0.00 (0.00%) CAD  |  CNSX  |  Mar 02, 16:00
More

Neural Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for NURL.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
BioMark Diagnostics, Inc. Upgrade
Justera Health Ltd. Upgrade
Wesana Health Holdings, Inc. --
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. Upgrade